Financial Ratios

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE1580.55-26.25 (-1.63 %)
PREV CLOSE ( ) 1606.80
OPEN PRICE ( ) 1607.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1580.00 (1)
VOLUME 15690
TODAY'S LOW / HIGH ( )1576.85 1614.60
52 WK LOW / HIGH ( )680.35 1703.8
NSE1580.05-23.6 (-1.47 %)
PREV CLOSE( ) 1603.65
OPEN PRICE ( ) 1602.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1580.05 (336)
VOLUME 849166
TODAY'S LOW / HIGH( ) 1577.45 1614.00
52 WK LOW / HIGH ( )680 1704.25
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)9.35-4.1527.7416.0634.01
   CEPS(Rs)21.407.1638.8227.5143.43
   DPS(Rs)4.004.006.506.005.00
   Book NAV/Share(Rs)401.40395.79405.03380.98373.46
   Tax Rate(%)19.34-16.8222.7730.8634.30
Margin Ratios
   Core EBITDA Margin(%)8.521.5617.1816.1223.57
   EBIT Margin(%)5.53-0.6714.049.3419.64
   Pre Tax Margin(%)4.66-1.2313.708.8919.35
   PAT Margin (%)3.76-1.4310.586.1512.71
   Cash Profit Margin (%)8.602.4714.8110.5316.23
Performance Ratios
   ROA(%)1.89-0.855.923.608.02
   ROE(%)2.35-1.047.064.269.48
   ROCE(%)3.30-0.479.196.3914.44
   Asset Turnover(x)0.500.600.560.590.63
   Sales/Fixed Asset(x)1.602.042.002.262.64
   Working Capital/Sales(x)2.872.691.691.431.62
Efficiency Ratios
   Fixed Capital/Sales(x)0.620.490.500.440.38
   Receivable days87.0181.97104.42113.21130.71
   Inventory Days99.9181.5979.6673.8867.63
   Payable days121.07115.55127.82125.75125.00
Valuation Parameters
   PER(x)69.320.0036.8036.7221.73
   PCE(x)30.28104.1826.3021.4317.02
   Price/Book(x)1.611.882.521.551.98
   Yield(%)0.620.540.641.020.68
   EV/Net Sales(x)2.662.944.192.302.94
   EV/Core EBITDA(x)25.5581.2821.3210.6710.62
   EV/EBIT(x)47.94-393.3027.7423.0014.04
   EV/CE(x)1.321.552.121.231.70
   M Cap / Sales2.622.884.192.422.94
Growth Ratio
   Net Sales Growth(%)-4.366.470.27-2.9112.57
   Core EBITDA Growth(%)175.48-80.39-8.80-24.2141.82
   EBIT Growth(%)810.40-105.2751.18-53.5430.14
   PAT Growth(%)325.34-114.9972.99-52.7214.44
   EPS Growth(%)325.09-114.9772.73-52.7714.34
Financial Stability Ratios
   Total Debt/Equity(x)0.030.040.020.000.00
   Current Ratio(x)2.092.383.724.244.75
   Quick Ratio(x)1.251.492.673.273.59
   Interest Cover(x)6.35-1.2041.1221.0167.04
   Total Debt/Mcap(x)0.020.020.010.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.